| 09-May-2025 |
Novartis India |
Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 inter alia to consider and approve The meeting of the Board of Directors of the Company is scheduled to be held on Friday May 09 2025 to inter alia consider and approve the Audited Financial Results of the Company for the financial year ended March 31 2025 and to recommend dividend on Equity Shares of the Company if any. |
| 09-May-2025 |
Indokem |
Indokem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Year ended 31st March 2025.
In view of this as per the Companys Code of Conduct to regulate monitor and report trading by insiders adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and for the purpose of the consideration of the financial results the trading window of the Company has been closed since 1st April 2025 and the same shall open 48 hours after declaration of Financial results of the Company. |
| 09-May-2025 |
TCI Industries |
TCI Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 inter alia to consider and approve Audited Financial Results for the fourth quarter and year ended March 31 2025. |
| 09-May-2025 |
Chola Financial |
Cholamandalam Financial Holdings Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 inter alia to consider and approve the audited financial results of the Company for the year ended March 31 2025. |
| 09-May-2025 |
Eveready Inds. |
Eveready Industries India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 inter alia to consider and approve
(i) annual audited financial results (standalone and consolidated) of the Company for the quarter and financial year ended 31st March 2025 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015; and
(ii) recommendation of dividend if any for the financial year ended 31st March 2025. |